Research Progress of NK Cells in Glioblastoma Treatment

Hao Wu1, Qi Liu2, Fenglu Wang1

  • 1Department of Neurosurgery, The Second Affiliated Hospital of Xi'an Medical University, Xi'an, People's Republic of China.

Oncotargets and Therapy
|January 23, 2025
PubMed

Insights

Natural killer (NK) cells show promise for glioma immunotherapy, but the tumor microenvironment

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Natural killer (NK) cells are crucial antitumor immune cells.
  • Glioma's immunosuppressive microenvironment hinders NK cell immunotherapy efficacy.

Purpose of the Study:

  • Review the role of NK cells in glioma immunotherapy.
  • Discuss NK cell development, function, and localization in gliomas.
  • Explore strategies to enhance NK cell-based glioma treatment.

Main Methods:

  • Literature review of NK cell research in glioma.
  • Analysis of current therapies targeting NK cells.
  • Examination of gene-modified NK cell strategies.

Main Results:

  • NK cell activity is modulated by receptors and the tumor microenvironment.
  • Various therapies (compounds, antibodies, cytokines) are being investigated.
  • Gene-modified NK cells represent a promising therapeutic trend.

Conclusions:

  • Understanding NK cell dynamics in gliomas is key.
  • Targeting NK cells and overcoming immune escape mechanisms are crucial for effective glioma immunotherapy.
  • Gene-edited NK cells offer novel therapeutic avenues for gliomas.